BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33076704)

  • 1. Partial splenic embolization is superior to intravenous somatostatin for decreasing portal pressure in cirrhotic patients: a dynamic self-controlled cohort study.
    Liu J; Sun X; Ganguli S; Wehrenberg-Klee EP; Bhan I; Zhao Y; Zhao L; Meng K; Sun R; Yu H; Sun G
    Scand J Gastroenterol; 2020 Nov; 55(11):1341-1346. PubMed ID: 33076704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of urapidil and cimetidine on wedged hepatic venous pressure and systemic hemodynamics in cirrhotic patients with portal hypertension].
    Li S; Feng H; Zhu J; Zhong C; Leng X; Du R
    Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):287-90. PubMed ID: 12828169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique.
    Silva-Junior G; Baiges A; Turon F; Torres F; Hernández-Gea V; Bosch J; García-Pagán JC
    Hepatology; 2015 Nov; 62(5):1584-92. PubMed ID: 26238376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of propofol sedation on the diagnostic accuracy of hepatic venous pressure gradient measurements in patients with cirrhosis.
    Ebrahimi F; Semela D; Heim M
    Hepatol Int; 2022 Aug; 16(4):817-823. PubMed ID: 34699037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of combined therapy using partial splenic embolization and transjugular retrograde obliteration for gastric varices with gastrorenal shunt.
    Chikamori F; Inoue A; Okamoto H; Kuniyoshi N; Kawashima T; Takase Y
    World J Surg; 2010 May; 34(5):1046-51. PubMed ID: 20162282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of Radix angelicae sinensis on systemic and portal hemodynamics in cirrhotics with portal hypertension].
    Huang Z; Guo B; Liang K
    Zhonghua Nei Ke Za Zhi; 1996 Jan; 35(1):15-8. PubMed ID: 9275639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the correlation between PPG and HVPG in patients with portal hypertension].
    Wang L; Song QK; Yue ZD; Zhao HW; Fan ZH; Wu YF; Liu FQ; Meng K; Zhang L; Jiang HG; Ding YN; Zhang Y
    Zhonghua Gan Zang Bing Za Zhi; 2022 Jul; 30(7):722-727. PubMed ID: 36038341
    [No Abstract]   [Full Text] [Related]  

  • 8. Low-dose midazolam sedation: an option for patients undergoing serial hepatic venous pressure measurements.
    Steinlauf AF; Garcia-Tsao G; Zakko MF; Dickey K; Gupta T; Groszmann RJ
    Hepatology; 1999 Apr; 29(4):1070-3. PubMed ID: 10094948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative randomized study on efficacy of losartan versus propranolol in lowering portal pressure in decompensated chronic liver disease.
    Agasti AK; Mahajan AU; Phadke AY; Nathani PJ; Sawant P
    J Dig Dis; 2013 May; 14(5):266-71. PubMed ID: 23280243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No.
    Thalheimer U; Bellis L; Puoti C; Burroughs AK
    Eur J Intern Med; 2011 Feb; 22(1):5-7. PubMed ID: 21238884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic non-infarction volume determines a clinically significant hepatic venous pressure gradient response to partial splenic embolization in patients with cirrhosis and hypersplenism.
    Ishikawa T; Sasaki R; Nishimura T; Matsuda T; Iwamoto T; Saeki I; Hidaka I; Takami T; Sakaida I
    J Gastroenterol; 2021 Apr; 56(4):382-394. PubMed ID: 33629147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin reduces gastric mucosal blood flow in patients with portal hypertensive gastropathy: a randomized, double-blind crossover study.
    Li MK; Sung JJ; Woo KS; Sanderson J; Leung NW; Yu LM; Tsui CP; Chung SC; Leung FW
    Dig Dis Sci; 1996 Dec; 41(12):2440-6. PubMed ID: 9011455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of hepatic and systemic haemodynamics following somatostatin administration in patients with hepatitis B-related cirrhosis.
    Hsia HC; Lin HC; Lee FY; Tsai YT; Lee SD; Meng HC; Chao Y; Wang SS; Lo KJ
    J Gastroenterol Hepatol; 1993; 8(1):15-20. PubMed ID: 8094983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic venous pressure gradient measurement: time to learn!
    Kumar A; Sharma P; Sarin SK
    Indian J Gastroenterol; 2008; 27(2):74-80. PubMed ID: 18695309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of somatostatin on portal and hepatic hemodynamics and portal venous pressure in cirrhotic patients with portal hypertension].
    Zhu J; Leng X; Feng H; Li S; Gan L; Zhang Y; Du R
    Zhonghua Wai Ke Za Zhi; 1998 Jul; 36(7):433-5. PubMed ID: 11825434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Portal and splanchnic hemodynamics after partial splenic embolization in cirrhotic patients with hypersplenism.
    Helaly AZ; Al-Warraky MS; El-Azab GI; Kohla MA; Abdelaal EE
    APMIS; 2015 Dec; 123(12):1032-9. PubMed ID: 26547369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observation of immediate and mid-term effects of partial spleen embolization in reducing hepatic venous pressure gradient.
    Zhao Y; Guo L; Huang Q; Zhang R; Sun X; Zhao L; Li C; Nie Y; Sun G; Liu J
    Medicine (Baltimore); 2019 Nov; 98(47):e17900. PubMed ID: 31764786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of catheter tip to hepatic vein ostium distance on the validity and prognostication of hepatic venous pressure gradient in cirrhosis.
    Tan HK; Tan AB; Teh KKJ; Gogna A; Too CW; Leong S; Chang JPE
    Sci Rep; 2023 Oct; 13(1):16980. PubMed ID: 37813906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension.
    Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A
    Digestion; 1985; 32(2):92-8. PubMed ID: 2864299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemodynamic effects of enalaprilat on portal hypertension in patients with HBsAg-positive cirrhosis.
    Chiang HT; Cheng JS; Lin M; Tseng WS; Chang JM; Lai KH
    J Gastroenterol Hepatol; 1995; 10(3):256-60. PubMed ID: 7548800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.